Helicobacter pylori and Alzheimer's disease: A possible link

European Journal of Internal Medicine

Volumn 15, Issue 6, 2004, Pages 381-386

  Malaguarnera, Mariano ^a   Bella, Rita ^a   Alagona, Giovanna ^a   Ferri, Raffaele ^b   Carnemolla, Anna ^a   Pennisi, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Alzheimer's disease; Folate; Helicobacter pylori; Homocysteine; Vitamin B 12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PYRIDOXAL 5 PHOSPHATE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; EDUCATION; FEEDING BEHAVIOR; FEMALE; HELICOBACTER INFECTION; HUMAN; MALE; MULTIINFARCT DEMENTIA; SOCIOECONOMICS;

EID: 7544246772     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2004.05.008     Document Type: Article

References (31)

1. C.W. Howden Clinical expressions of Helicobacter pylori infection Am. J. Med. 20 100 1996 27S 32S [discussion 32S-34S]
2. N.J. Wald, M.R. Law, J.K. Morris, and A.M. Bagnall Helicobacter pylori infection and mortality from ischemic heart disease: negative results from a large, prospective study BMJ 315 1997 1199 1201
3. P. Patel, M.A. Mendall, D. Carrington, D.P. Strachan, E. Leatham, and N. Molineaux Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors BMJ 311 1995 711 714
4. V. Pasceri, G. Cammarota, G. Patti, L. Cuoco, A. Gasbarrini, and R.L. Grillo Association of virulent Helicobacter pylori strains with ischemic heart disease Circulation 97 1998 1675 1679
5. A.J. Grau, F. Buggle, C. Lichy, T. Brandt, H. Becher, and J. Rudi Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin J. Neurol. Sci. 1 186 2001 1 5
6. H.S. Markus, and M.A. Mendall Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma J. Neurol. Neurosurg. Psychiatry 64 1998 104 107
7. S.F. Ameriso, E.A. Fridman, R.C. Leiguarda, and G.E. Sevlever Detection of Helicobacter pylori in human carotid atherosclerotic plaques Stroke 32 2001 385 391
8. F. Pasquier, and D. Leys Why are stroke patients prone to develop dementia? J. Neurol. 244 1997 135 142
9. D.A. Snowdon, L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner, and W.R. Markesbery Brain infarction and the clinical expression of Alzheimer disease. The Nun Study JAMA 12 277 1997 813 817
10. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research 1993 World Health Organization Geneva, Switzerland 36 40
11. T. Erkinjuntti, D. Inzitari, L. Pantoni, A. Wallin, P. Scheltens, and K. Rockwood Research criteria for subcortical vascular dementia in clinical trials J. Neural. Transm., Suppl. 59 2000 23 30
12. J.P. Dick, R.J. Guiloff, A. Stewart, J. Blackstock, C. Bielawska, and E.A. Paul Mini-Mental State Examination in neurological patients J. Neurol. Neurosurg. Psychiatry 47 1984 496 499
13. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
14. Guidelines for the management of mild hypertension: memorandum from a World Health Organization-International Society of Hypertension meeting J. Hypertens. 11 1993 905 918
15. A. Araki, and Y. Sako Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection J. Chromat. 422 1987 43 52
16. Y. Shin Buering, R. Rasshofer, and W.A. Endres A new enzymatic method for pyridoxal 5′-phosphate determination J. Inherit. Metab. Dis. 4 1981 123 124
17. E. Danielli A fluorometric enzyme-linked immunosorbent assay for serological diagnosis of Helicobacter pylori infection Eur. J. Gastroenterol. Hepatol. 5 Suppl. 2 1993 557 559
18. W.T. Friedewald, R.I. Levy, and D.S. Friedrickson Evaluation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
19. R. Clarke, L. Daly, K. Robinson, E. Naughten, S. Cahalane, and B. Fowler Hyperhomocysteinemia: an independent risk factor for vascular disease N. Engl. J. Med. 324 17 1991 1149 1155
20. S. Seshadri, A. Beiser, and J. Selhub Plasma homocysteine as a risk factor for dementia and Alzheimer's disease N. Engl. J. Med. 14 346 2002 476 483
21. 12, and serum total homocysteine levels in confirmed Alzheimer disease Arch. Neurol. 55 11 1998 1449 1455
22. A. McCaddon, G. Davies, and P. Hudson Total serum homocysteine in senile dementia of Alzheimer type Int. J. Geriatr. Psychiatry 13 1998 235 239
23. G.J. Hankey, and J.W. Eikelboom Homocysteine and vascular disease Lancet 31 354 1999 407 413
24. A.R. White, X. Huang, and M.F. Jobling Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways J. Neurochem. 76 2001 1509 1520
25. P.L. McGeer, and E.G. McGeer The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases Brain Res. Brain Res. Rev. 21 2 1995 195 218
26. W.A. Ghali, H. Quan, and T.E. Feasby Helicobacter pylori and cerebrovascular disease Stroke 32 8 2001 1936
27. J. Danesh, R. Collins, and R. Peto Chronic infections and coronary heart disease: is there a link? Lancet 9 350 1997 430 436
28. J.J. Sung, and J.E. Sanderson Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease Heart 76 4 1996 305 307
29. 12 deficiency and Alzheimer disease Arch. Neurol. 57 4 2000 607 608
30. J. Kansan, and A. Labigne Heat shock proteins of Helicobacter pylori Aliment. Pharmacol. Ther. 10 Suppl. 1 1996 51 56
31. K. Nilsson, L. Gustafson, and B. Hultberg The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population Clin. Chem. 46 2000 691 696